Psychiatry & Neurology, Neuromuscular Medicine · Nashville, TN
NPI
1013064989
Since 2007
Specialty
Psychiatry & Neurology, Neuromuscular Medicine
Code 2084N0008X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1601 21st Ave S, Department of Neurology
Nashville, TN, 37212
Phone (615) 322-7246
Groups this clinician bills Medicare through
Medicare paid, 2024
$29K
457 services
Medicare patients, 2024
290
Average age 70
Drug cost, 2024
$3.2M
1,336 prescriptions
Company payments, 2025
$99.99
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christopher Lee was code 99214 (office e&m - established), 117 times for 103 patients. In total Christopher Lee billed 457 services in 25 codes, and Medicare paid $29K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-06-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 117 | 103 | $61.94 | $7,247 |
| 95885 Electrical Nerve Conductivity | Facility | 47 | 36 | $12.79 | $601 |
| 99215 Office E&M - Established | Facility | 41 | 41 | $100.96 | $4,139 |
| 99213 Office E&M - Established | Facility | 40 | 39 | $46.89 | $1,876 |
| 99204 Office E&M - New | Facility | 37 | 37 | $88.72 | $3,283 |
| 99214 Office E&M - Established | Office | 27 | 22 | $87.26 | $2,356 |
| 99213 Office E&M - Established | Office | 21 | 20 | $61.25 | $1,286 |
| 95909 Electrical Nerve Conductivity | Facility | 19 | 19 | $54.77 | $1,041 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 18 | 18 | $12.93 | $233 |
| 95910 Electrical Nerve Conductivity | Facility | 14 | 14 | $70.02 | $980 |
| 99215 Office E&M - Established | Office | 13 | 12 | $118.68 | $1,543 |
| 95886 Electrical Nerve Conductivity | Facility | 11 | 11 | $28.55 | $314 |
By year: 2022 $26K for 407 services; 2023 $23K for 383 services; 2024 $29K for 457 services.
Medicare prescription drug claims, 2024
In 2024, the drug Christopher Lee prescribed most often to Medicare patients was Gabapentin, with 137 prescriptions and refills. In total Christopher Lee wrote 1,336 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 137 | 282 | 48 | $3,340 |
| Prednisone Generic | 116 | 278 | 36 | $1,139 |
| Pregabalin Generic | 104 | 132 | 22 | $1,416 |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 78 | 78 | Under 11 | $289K |
| Pyridostigmine Bromide Generic | 69 | 140 | 29 | $7,565 |
| Baclofen Generic | 63 | 134 | 21 | $706 |
| Privigen Immun Glob G(Igg)/Pro/Iga 0-50 | 52 | 52 | Under 11 | $418K |
| Duloxetine Hcl Generic | 51 | 145 | 20 | $1,140 |
| Gammagard Liquid Immun Glob G(Igg)/Gly/Iga Ov50 | 39 | 39 | Under 11 | $412K |
| Diazepam Generic | 32 | 32 | Under 11 | $247 |
| Bivigam Immun Glob G(Igg)/Gly/Iga Ov50 | 30 | 30 | Under 11 | $325K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 30 | 30 | Under 11 | $864 |
| Memantine Hcl Generic | 28 | 64 | 12 | $952 |
| Radicava Ors Edaravone | 25 | 25 | Under 11 | $362K |
| Riluzole Generic | 22 | 35 | Under 11 | $10K |
Brand drugs: - claims; generic drugs: 1,014 claims; opioid claims: 79.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christopher Lee $99.99 ($99.99 in general payments such as food, travel and fees) from 1 company. The largest payer was Janssen Biotech, Inc. with $99.99.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 1 | $99.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.